Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018087656) A NEW FORMULATION FOR INTRANASAL ADMINISTRATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/087656 International Application No.: PCT/IB2017/056945
Publication Date: 17.05.2018 International Filing Date: 07.11.2017
IPC:
A61K 38/18 (2006.01) ,A61K 9/00 (2006.01) ,A61P 25/28 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
18
Growth factors; Growth regulators
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
28
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants:
UNIVERSITÀ CATTOLICA DEL SACRO CUORE [IT/IT]; Largo Agostino Gemelli 1 20123 Milano (MI), IT
Inventors:
CHIARETTI, Antonio; IT
FALSINI, Benedetto; IT
SCAMBIA, Giovanni; IT
RICCARDI, Riccardo; IT
MANNI, Luigi; IT
Agent:
PREDAZZI, Valentina; IT
Priority Data:
10201600011242008.11.2016IT
Title (EN) A NEW FORMULATION FOR INTRANASAL ADMINISTRATION
(FR) NOUVELLE FORMULATION POUR ADMINISTRATION INTRANASALE
Abstract:
(EN) The present invention relates to pharmaceutical compositions comprising NGF or molecules with NGF-like activity for use in the treatment of traumatic brain injury by means of intranasal administration, a method for treating traumatic brain injury by means of intranasal administration of NGF or molecules with NGF-like activity, and an associated pharmaceutical kit.
(FR) La présente invention concerne des compositions pharmaceutiques comprenant du NGF ou des molécules ayant une activité de type NGF destinées à être utilisées dans le traitement d'une lésion cérébrale traumatique au moyen d'une administration intranasale, une méthode de traitement d'une lésion cérébrale traumatique au moyen d'une administration intranasale de NGF ou de molécules ayant une activité de type NGF, et un kit pharmaceutique associé.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: Italian (IT)